These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 8969995

  • 1. Prochlorperazine-induced neuroleptic malignant syndrome.
    Pesola GR, Quinto C.
    J Emerg Med; 1996; 14(6):727-9. PubMed ID: 8969995
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome.
    Edwards MS.
    Pediatrics; 1991 Nov; 88(5):1074. PubMed ID: 1796971
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME, Browning LA, Parker D, Saely S.
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [Abstract] [Full Text] [Related]

  • 4. Neuroleptic malignant syndrome associated with prochlorperazine.
    Manser TJ, Warner JF.
    South Med J; 1990 Jan; 83(1):73-4. PubMed ID: 2300839
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma.
    Bhan S, Kulkarni V, Mehta Y, Sharma KK, Trehan N, Suri ML.
    Asian Cardiovasc Thorac Ann; 2002 Dec; 10(4):365-6. PubMed ID: 12538292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient.
    Nachreiner R, Balledux J, Zieger M, Viegas O, Sood R.
    J Burn Care Res; 2006 Dec; 27(2):237-41. PubMed ID: 16566575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.
    Baca L, Martinelli L.
    Neurology; 1990 Nov; 40(11):1797-8. PubMed ID: 2234440
    [Abstract] [Full Text] [Related]

  • 11. Tardive dyskinesia as a result of long-term prochlorperazine use.
    Alberts VA, Catalano G, Poole MA.
    South Med J; 1996 Oct; 89(10):989-91. PubMed ID: 8865792
    [Abstract] [Full Text] [Related]

  • 12. [Association of an acute thyrotoxic crisis and the neuroleptic malignant syndrome. Efficacy of bromocriptine].
    Parini M, Archambeaud-Mouveroux F, Vincent D, Papapietro P, Dallet A.
    Presse Med; 1984 Sep 15; 13(31):1902. PubMed ID: 6237335
    [No Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome with promethazine.
    Mendhekar DN, Andrade CR.
    Aust N Z J Psychiatry; 2005 Apr 15; 39(4):310. PubMed ID: 15777370
    [No Abstract] [Full Text] [Related]

  • 14. [Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine].
    Verhoeven WM, Elderson A.
    Ned Tijdschr Geneeskd; 1985 Jan 12; 129(2):76-8. PubMed ID: 3969176
    [No Abstract] [Full Text] [Related]

  • 15. The neuroleptic malignant syndrome after open heart surgery: successful treatment with bromocriptine.
    Lieberman A, Pasternack P, Colvin S.
    N Y State J Med; 1987 Jun 12; 87(6):362-3. PubMed ID: 3497368
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dopamine agonists and neuroleptic malignant syndrome.
    Rosse R, Ciolino C.
    Am J Psychiatry; 1985 Feb 12; 142(2):270-1. PubMed ID: 3970258
    [No Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD, Sczesni B, Fahn S, Gross J, Donovan K, van Bakel A, Wiley MK.
    Nervenarzt; 1988 Feb 12; 59(2):103-9. PubMed ID: 2896306
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.